CIPLA vs DRREDDY — stock comparison
Cipla Ltd (CIPLA), Dr Reddys Laboratories Ltd (DRREDDY): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, CIPLA grades highest (B+ 71). Not investment advice.
1-year price performance — higher line = stronger return
■ CIPLA -8.2%■ DRREDDY +12.2%Past year, rebased to 100
| CIPLA | DRREDDY | |
|---|---|---|
| Traddx grade | B+ (71) | B (61) |
| Price | ₹1,397.80 | ₹1,388.60 |
| Today | 0.34% | 0.84% |
| P/E | 36.20 | 41.20 |
| ROE | 11.60% | 11.20% |
| Net margin | 15.53% | 12.49% |
| Debt / equity | 0.02 | 0.19 |
| 52-week high | ₹1,539.25 | ₹1,414.40 |
| 52-week low | ₹1,165.55 | ₹1,080.05 |
Green = the strongest figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open CIPLA live → Open DRREDDY live →